Therefore, inhibition of mTORC1 will thwart cell protein synthesis and proliferation; nonetheless, as mentioned earlier, the inhibition of mTORC1 without impeding mTORC2 may result in compensatory stimulation of PI3K/Akt signaling pathway and promotion of cancer survival. Here, AKT1 is linked to cancer.